AVEO : Summary for AVEO Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets close in 1 hr 32 mins

AVEO Pharmaceuticals, Inc. (AVEO)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.56-0.09 (-13.83%)
As of 2:28PM EDT. Market open.
People also watch
PBMDANTHARQLINFISNTA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.65
Open0.55
Bid0.55 x 800
Ask0.55 x 800
Day's Range0.50 - 0.58
52 Week Range0.50 - 1.15
Volume4,196,852
Avg. Volume325,221
Market Cap61.99M
Beta1.82
PE Ratio (TTM)-1.28
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire5 hours ago

    AVEO Announces Pricing of $15.0 Million Public Offering of Common Stock

    AVEO Pharmaceuticals, Inc. today announced that it has priced an underwritten public offering of 30,000,000 shares of common stock at a price to the public of $0.50 per share, before underwriting discounts, which would result in aggregate gross proceeds of approximately $15 million.

  • Business Wire8 hours ago

    AVEO Announces Proposed Offering of Common Stock

    AVEO Pharmaceuticals, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

  • AVEO (AVEO) Reports Narrower-than-Expected Loss in Q4
    Zacks5 days ago

    AVEO (AVEO) Reports Narrower-than-Expected Loss in Q4

    AVEO Pharmaceuticals, Inc. (AVEO) reported a narrower-than-expected loss in the fourth-quarter 2016.